HOME Top Market Reports Nasal Drug Delivery Technology Market by Dosage Form (Nasal Drops, Sprays, Powder, Gel), System (Multidose, Unit Dose, BI-Dose), Therapeutic Applications (Rhinitis, Congestion, Vaccinations), End User (Hospitals, Homecare) - Global Forecast to 2021

Nasal Drug Delivery Technology Market by Dosage Form (Nasal Drops, Sprays, Powder, Gel), System (Multidose, Unit Dose, BI-Dose), Therapeutic Applications (Rhinitis, Congestion, Vaccinations), End User (Hospitals, Homecare) - Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: January 2017
Report Code: MD 4892

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global nasal drug delivery technology market is projected to reach USD 64.20 Billion by 2021 from USD 44.00 Billion in 2016, at a CAGR of 6.5% during the forecast period. This market is segmented based on dosage form, therapeutic application, end user, system, container, and region.

Increasing patient preference for nasal drug delivery as a result of easy administration & better efficacy and growing adoption of self-administration practices are some of the major factors driving the growth of the market. Intranasal drug delivery is one of the most preferred drug delivery routes among patients as well as healthcare providers. This can be majorly attributed to the non-invasive nature of this route of delivery and the fact that drug absorbability is higher through the nasal route.

The nasal drug delivery technology market is expected to witness significant growth in the coming years, due to the high demand and adoption of OTC products. Various pharmaceutical companies are focusing on the development of OTC drugs. This is expected to create growth opportunities for players offering nasal drugs, especially nasal sprays and drops which are majorly sold as generic OTC medicines.

North America is projected to dominate the market in 2016, with the U.S. accounting for a major share. However, Asia is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to investments by major companies in the area of R&D activities. Also, this region has low costs of labor and clinical trials, which has further served to draw market players to Asia.

Apart from the comprehensive geographical analysis, product analysis, and market sizing; this report also provides a competitive landscape that covers the growth strategies adopted by industry players in the last three years. In addition, the company profiles comprise basic views on the key players and their product portfolios, developments, and strategies adopted. The above-mentioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, change their strategic approach, R&D investments for innovations in products and technology, and levels of output in order to remain successful.

The nasal drug delivery technology market is at a very nascent stage with various players. Prominent players in this market include Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Pfizer, Inc. (U.S.), AstraZeneca plc. (U.S.), AptarGroup (U.S.), and GlaxoSmithKline plc (U.K.).

Target Audience:

  • Nasal Drug Delivery Technology Manufacturers
  • Public and Private Physicians
  • Healthcare Institutions (Medical Data Centers)
  • Research & Clinical Laboratories
  • Distributors and Suppliers of Nasal Drug Delivery Technologies
  • Health Insurance Payers
  • Market Research and Consulting Firms

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This report categorizes the nasal drug delivery technology market into the following segments and subsegments.

Nasal Drug Delivery Technology Market, by Dosage Form

  • Sprays
  • Drops & Liquids
  • Powders
  • Gels

Nasal Drug Delivery Technology Market, by Container

  • Pressurized Containers
  • Non-pressurized Containers

Nasal Drug Delivery Technology Market, by System

  • Multi-dose Systems
  • Bi-dose Systems
  • Unit-dose Systems

Nasal Drug Delivery Technology Market, by Therapeutic Application

  • Allergic And Non-allergic Rhinitis
  • Nose Congestion
  • Vaccination
  • Other Therapeutic Applications

Nasal Drug Delivery Technology Market, by End User

  • Home Care Settings
  • Hospitals

Nasal drug delivery technology Market, by Region     

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Rest of Europe (RoE)
  • Asia
    • China
    • India
    • Japan
    • Rest of Asia (RoA)
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to 5).

Further Split of the RoW X-ray Detectors Market

Nasal drug delivery technology market size and growth rate estimates of Latin America, Pacific, and Middle East & Africa.

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
    1.4 Limitations
    1.5 Market Stakeholders

2 Research Methodology
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Key Data Point From Secondary Sources
    2.4 Key Data Point From Primary Sources
    2.5 Key Industry Insights
    2.6 Assumptions

3 Executive Summary

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
           5.3.1 Market Drivers
                    5.3.1.1 Increasing Patient Preference for Nasal Drug Delivery as A Result of Easy Administration and Better Efficacy
                    5.3.1.2 Growing Adoption of Self-Administration Practices
           5.3.2 Market Restraints
                    5.3.2.1 Complications Associated With the Overuse of Nasal Sprays
           5.3.3 Market Opportunities
                    5.3.3.1 Over-The-Counter Nasal Drugs
                    5.3.3.2 Increasing Focus on Alternative Routes Such as Nasal Drug Delivery
           5.3.4 Market Challenges
                    5.3.4.1 Regulatory Hurdles

6 Regulatory Scenario

7 Global Nasal Drug Delivery Technology Market, By Dosage Form
    7.1 Introduction
    7.2 Nasal Spray
    7.3 Nasal Drops and Liquids
    7.4 Nasal Gels
    7.5 Nasal Powders
    7.6 Others

8 Global Nasal Drug Delivery Technology Market, By Containers
    8.1 Introduction
    8.2 Non-Pressurized Containers
    8.3 Pressurized Containers

9 Global Nasal Drug Delivery Technology Market, By Systems
    9.1 Introduction
    9.2 Multi Dose
    9.3 Bi-Dose
    9.4 Unit Dose

10 Global Nasal Drug Delivery Technology Market, By Therapeutic Application
     10.1 Allergic and Non-Allergic Rhinitis
     10.2 Nasal Congestion
     10.3 Vaccinations
     10.5 Other Applications

11 Global Nasal Drug Delivery Technology Market, By End User
     11.1 Introduction
     11.2 Hospitals
     11.3 Home Health Care

12 Geographic Analysis
     12.1 Introduction
     12.2 North America
             12.2.1 U.S.
             12.2.2 Canada
     12.3 Europe
             12.3.1 Germany
             12.3.2 France
             12.3.3 U.K.
             12.3.4 Rest of the Europe (RoE)
     12.4 Asia
             12.4.1 Japan
             12.4.2 India
             12.4.3 China
             12.4.4 Roa
     12.5 Rest of the World (RoW)

13 Competitive Landscape
     13.1 Overview
     13.2 Market Share Analysis
     13.3 Competitive Situations & Trends

14 Company Profiles**
     14.1 Introduction
     14.2 Merck & Co., Inc.
     14.3 Novartis AG
     14.4 Glaxosmithkline PLC
     14.5 Johnson & Johnson Services, Inc.
     14.6 Pfizer Inc.
     14.7 Astrazeneca PLC
     14.8 Aptargroup, Inc.
     14.9 Aegis Therapeutics LLC
     14.10 3M
             14.10.1 MnM View
     14.11 Becton, Dickinson and Company

* The Segment/Chapters Will Be Added According to the Availability of the Information
** Tentative List of Companies Added, This is Subjected to the Addition and Deletion of Companies

15 Appendix
     15.1 Insights From Industry Experts 
     15.2 Discussion Guide 
     15.3 Knowledge Store  
     15.4 Introducing RT: Real Time Market Intelligence 
     15.5 Related Reports 
     15.6 Authors Details  


List of Tables (95 Tables)

Table 1 Nasal Drug Delivery Technology Market Size, By Dosage Form, 2014–2021 (USD Million)
Table 2 Nasal Sprays Drug Delivery Technology Market Size, By Region, 2014–2021 (USD Million)
Table 3 Nasal Drops & Liquids Drug Delivery Technology Market Size, By Region, 2014–2021 (USD Million)
Table 4 Nasal Drops & Liquids Drug Delivery Technology Market Size, By Region, 2014–2021 (USD Million)
Table 5 Nasal Drug Delivery Market Size, By Container Type, 2014-2021 (USD Million)
Table 6 Nasal Drug Delivery Market Size for Non-Pressurized Containers, By Region, 2014-2021 (USD Million)
Table 7 Nasal Drug Delivery Market Size for Pressurized Containers, By Region, 2014-2021 (USD Million)
Table 8 Market Size, By System, 2014–2021 (USD Million)
Table 9 Market Size for Multi-Dose Systems, By Region, 2014–2021 (USD Million)
Table 10 Market Size for Bi-Dose Systems, By Region, 2014–2021 (USD Million)
Table 11 Market Size for Unit-Dose Systems, By Region, 2014–2021 (USD Million)
Table 12 Nasal Drug Delivery Market Size, By Therapeutic Application, 2014-2021 (USD Million)
Table 13 Nasal Drug Delivery Market Size for Allergic and Non-Allergic Rhinitis, By Region, 2014–2021 (USD Million)
Table 14 Nasal Drug Delivery Market Size for Nasal Congestion, By Region, 2014-2021 (USD Million)
Table 15 Nasal Drug Delivery Market Size for Vaccination, By Region, 2014-2021 (USD Million)
Table 16 Nasal Drug Delivery Market Size for Other Therapeutic Applications, By Region, 2014-2021 (USD Million)
Table 17 Nasal Drug Delivery Market Size for Other Therapeutic Applications, By Region, 2014-2021 (USD Million)
Table 18 Nasal Drug Delivery Market Size for Homecare Settings, By Region, 2014–2021 (USD Million)
Table 19 Nasal Drug Delivery Market Size for Hospitals, By Region, 2014–2021 (USD Million)
Table 20 Global Nasal Drug Delivery Technology Market Size, By Region, 2014–2021 (USD Million)
Table 21 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 22 North America: Market Size, By System, 2014–2021 (USD Million)
Table 23 North America: Market Size, By Dosage Form, 2014–2021 (USD Million)
Table 24 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 25 North America: Market Size, By Container, 2014–2021 (USD Million)
Table 26 North America: Market Size, By Therapeutic Application, 2014–2021 (USD Million)
Table 27 U.S.: Market Size, By System, 2014–2021 (USD Million)
Table 28 U.S.: Nasal Drug Delivery Market, By Dosage Form, 2014–2021 (USD Million)
Table 29 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 30 U.S.: Market Size, By Container, 2014–2021 (USD Million)
Table 31 U.S.: Market Size, By Therapeutic Application, 2014–2021 (USD Million)
Table 32 Canada: Market Size, By System, 2014–2021 (USD Million
Table 33 Canada: Market Size, By Dosage Form, 2014–2021 (USD Million)
Table 34 Canada: Market Size, By End User, 2014–2021 (USD Million)
Table 35 Canada: Market Size, By Container, 2014–2021 (USD Million)
Table 36 Canada: Market Size, By Therapeutic Application, 2014–2021 (USD Million)
Table 37 Europe: Market Size, By System, 2014–2021 (USD Million)
Table 38 Europe: Market Size, By Dosage Form, 2014–2021 (USD Million)
Table 39 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 40 Europe: Market Size, By Container, 2014–2021 (USD Million)
Table 41 Europe: Market Size, By Therapeutic Application, 2014–2021 (USD Million)
Table 42 Germany: Market Size, By System, 2014–2021 (USD Million)
Table 43 Germany: Market Size, By Dosage Form, 2014–2021 (USD Million)
Table 44 Germany: Market Size, By End User, 2014–2021 (USD Million)
Table 45 Germany: Market Size, By Container, 2014–2021 (USD Million)
Table 46 Germany: Market Size, By Therapeutic Application, 2014–2021 (USD Million)
Table 47 U.K.: Market Size, By System, 2014–2021 (USD Million)
Table 48 U.K.: Market Size, By Dosage Form, 2014–2021 (USD Million)
Table 49 U.K.: Market Size, By End User, 2014–2021 (USD Million)
Table 50 U.K.: Market Size, By Container, 2014–2021 (USD Million)
Table 51 U.K.: Market Size, By Therapeutic Application, 2014–2021 (USD Million)
Table 52 France: Market Size, By System, 2014–2021 (USD Million)
Table 53 France: Market Size, By Dosage Form, 2014–2021 (USD Million)
Table 54 France: Market Size, By End User, 2014–2021 (USD Million)
Table 55 France: Market Size, By Container, 2014–2021 (USD Million)
Table 56 France: Market Size, By Therapeutic Application, 2014–2021 (USD Million)
Table 57 RoE: Market Size, By System, 2014–2021 (USD Million)
Table 58 RoE: Market Size, By Dosage Form, 2014–2021 (USD Million)
Table 59 RoE: Market Size, By End User, 2014–2021 (USD Million)
Table 60 RoE: Market Size, By Container, 2014–2021 (USD Million)
Table 61 RoE: Market Size, By Therapeutic Application, 2014–2021 (USD Million)
Table 62 Asia: Market Size, By System, 2014–2021 (USD Million)
Table 63 Asia: Market, By Dosage Form, 2014–2021 (USD Million)
Table 64 Asia: Market Size, By End User, 2014–2021 (USD Million)
Table 65 Asia: Market Size, By Container, 2014–2021 (USD Million)
Table 66 Asia:Market Size, By Therapeutic Application, 2014–2021 (USD Million)
Table 67 Japan: Market Size, By System, 2014–2021 (USD Million)
Table 68 Japan: Market Size, By Dosage Form, 2014–2021 (USD Million)
Table 69 Japan: Market Size, By End User, 2014–2021 (USD Million)
Table 70 Japan: Market Size, By Container, 2014–2021 (USD Million)
Table 71 Japan: Market Size, By Therapeutic Application, 2014–2021 (USD Million)
Table 72 China: Market Size, By System, 2014–2021 (USD Million)
Table 73 China: Market Size, By Dosage Form, 2014–2021 (USD Million)
Table 74 China: Market Size, By End User, 2014–2021 (USD Million)
Table 75 China: Market Size, By Container, 2014–2021 (USD Million)
Table 76 China: Market Size, By Therapeutic Application, 2014–2021 (USD Million)
Table 77 India: Market Size, System, 2014–2021 (USD Million)
Table 78 India: Nasal Drug Delivery Market Size, By Dosage Form, 2014–2021 (USD Million)
Table 79 India: Market Size, By End User, 2014–2021 (USD Million)
Table 80 India: Market Size, By Container, 2014–2021 (USD Million)
Table 81 India: Market Size, By Therapeutic Application, 2014–2021 (USD Million)
Table 82 RoA: Market Size, By System, 2014–2021 (USD Million)
Table 83 RoA: Market Size, By Dosage Form, 2014–2021 (USD Million)
Table 84 RoA: Market Size, By End User, 2014–2021 (USD Million)
Table 85 RoA: Market Size, By Container, 2014–2021 (USD Million
Table 86 RoA: Market Size, By Therapeutic Application, 2014–2021 (USD Million)
Table 87 RoW: Market Size, By System, 2014–2021 (USD Million)
Table 88 RoW: Market Size, By Dosage Form, 2014–2021 (USD Million)
Table 89 RoW: Market Size, By End User, 2014–2021 (USD Million)
Table 90 RoW: Market Size, By Container, 2014–2021 (USD Million)
Table 91 RoW: Market Size, By Therapeutic Application, 2014–2021 (USD Million)
Table 92 Product Launches and Approvals, 2014–2016
Table 93 Collaborations, 2014–2016
Table 94 Expansions, 2014–2016
Table 95 Market Ranking for the Key Players in 2016


List of Figures (36 Figures)

Figure 1 Segmentation & Coverage
Figure 2 Research Design
Figure 3 Nasal Drug Delivery Market: Top Down Approach
Figure 4 Nasal Drug Delivery Market: Bottom Up Approach
Figure 5 Data Triangulation Methodology
Figure 6 Assumptions for the Study
Figure 7 Nasal Drug Delivery Technology Market, By Dosage Form, 2016 vs 2021
Figure 8 Nasal Drug Delivery Technology Market, By Systems, 2016 vs 2021
Figure 9 Nasal Drug Delivery Technology Market, By End User, 2016 vs 2021
Figure 10 Nasal Drug Delivery Technology Market, By Therapeutic Application, 2016 vs 2021
Figure 11 Nasal Drug Delivery Technology Market, By Container, 2016 vs 2021
Figure 12 Nasal Drug Delivery Technology Market, By Region, 2016-2021
Figure 13 Nasal Drug Delivery Technology Market to Showcase Lucrative Growth Opportunities During the Forecast Period
Figure 14 Home Care Settings Segment is Expected to Grow at A Highest CAGR, By End User, (2016-2021)
Figure 15 Multi-Dose Systems Segment to Account for the Largest Share of the Market, By System, in 2016
Figure 16 Alleric and Non-Allergic Rhinitis to Dominate the Market, By Therapeutic Application, in 2016
Figure 17 Nasal Drug Delivery Technology Market in Japan to Register the Highest CAGR (2016–2021)
Figure 18 Nasal Drug Delivery Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 North America: Nasal Drug Delivery Technology Market Snapshot
Figure 20 Europe: Nasal Drug Delivery Technology Market Snapshot
Figure 21 Asia: Nasal Drug Delivery Technology Market Snapshot
Figure 22 Key Players Adopted Organic and Inorganic Growth Strategies Between 2014 and 2016
Figure 23 Market Evolution Framework
Figure 24 Battle for Market Share: Product Launches and Approvals—Key Strategies Adopted By Market Players
Figure 25 Geographic Revenue Mix of Top Five Market Players (2015)
Figure 26 Merck & Co., Inc.: Company Snapshot (2015)
Figure 27 Novartis AG: Company Snapshot (2015)
Figure 28 Glaxosmithkline PLC: Company Snapshot (2015)
Figure 29 Johnson & Johnson Services, Inc.: Company Snapshot (2015)
Figure 30 Pfizer, Inc: Company Snapshot (2015)
Figure 31 Astrazeneca PLC: Company Snapshot (2015)
Figure 32 Aptargroup, Inc.: Company Snapshot (2015)
Figure 33 Aegis Therapeutics, LLC: Company Snapshot (2015)
Figure 34 3M: Company Snapshot (2015)
Figure 35 Becton, Dickinson and Company: Company Snapshot (2015)
Figure 36 Insights From Industry Experts

The global nasal drug delivery technology market is projected to reach USD 64.20 Billion by 2021 from USD 44.00 Billion in 2016, at a CAGR of 6.5% during the forecast period. Increasing patient preference for nasal drug delivery as a result of easy administration & better efficacy and growing adoption of self-administration practices are some of the major factors driving the growth of the market.

Furthermore, growth among over-the-counter nasal drugs and increasing focus on alternative routes of drug delivery such as nasal drug delivery offer significant growth opportunities for player operating in the market. On the other hand, complications associated with the overuse of nasal sprays may restraint the growth of the market.

The market is segmented based on dosage form, therapeutic application, end user, system, container, and region. On the basis of system, the market is segmented into multi-dose systems, bi-dose systems, and unit-dose systems. In 2016, the multi-dose drug delivery systems segment is expected to account for the largest share of the market. This can primarily be attributed to the growing preference for multi-dose drug delivery as these systems provide quick and effective delivery of drugs into the bloodstream.

On the basis of container, the market is segmented into pressurized and non-pressurized containers. In 2016, the non-pressurized containers segment is expected to account for the largest share of the market. This can be primarily attributed to advantages such as better versatility and reliability, instant availability, self-containment, better portability, and low-cost medical aerosol delivery. In addition, the increasing usage of these devices for the treatment of reversible airflow obstruction resulting from asthma and chronic obstructive pulmonary disease (COPD) is expected to further drive the growth of this market in the coming years.

On the basis of dosage form, the market is segmented into the sprays, drops & liquids, nasal powders, and nasal gels. In 2016, the nasal sprays segment is expected to account for the largest share of the market. The large share of this market segment can be attributed to factors such as increased patient compliance due to reduced irritation caused by dust and pollen, affordable prices of nasal sprays, and delivery of large doses of drugs.

On the basis of therapeutic application, the market is segmented into allergic and non-allergic rhinitis, nasal congestion, vaccination, and other therapeutic applications (osteoporosis, pain management, and sexual dysfunction). The allergic and non-allergic rhinitis segment is expected to register the highest CAGR during the forecast period. The high growth in this segment can primarily be attributed to the increasing prevalence of allergic and non-allergic rhinitis and growing preference for nasal drugs for its treatment.

On the basis of end user, the market is segmented into hospitals and home care settings. In 2016, the home care settings segment is expected to account for the largest share of the market, primarily due to the increasing preference for self-administration among patients

Nasal Drug Delivery Technology Market

The market is dominated by North America, followed by Europe, Asia, and the Rest of the World. While, North America is expected to dominate the market in 2016, Asia is expected to grow at the highest CAGR during the forecast period. Opportunities in the Asian market have attracted huge investments by major companies in the area of R&D activities. In addition, the region has low costs of labor and clinical trials, which has further served to draw market players to Asia.

Prominent players in the nasal drug delivery technology market include Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Pfizer, Inc. (U.S.), AstraZeneca plc. (U.S.), AptarGroup (U.S.), and GlaxoSmithKline plc (U.K.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo